The European Medicines Agency cooperates with many of the world’s largest regulatory bodies outside the European Union (EU) in areas such as inspections, safety of medicines and exchange of information on issues of mutual concern.
International cooperation is a key area of work for the Agency, in an increasingly globalised pharmaceutical market and a world in which public health issues such as the 2009 (H1N1) influenza virus go beyond national borders.
Agreements with other regulators
The Agency has agreements in place with regulators in these countries:
The Agency also supports the European Commission's collaboration on pharmaceuticals with these countries: